India remains a significant center for the manufacture of Hydroxychloroquine Sulphate API , with key hubs concentrated in major cities. Mumbai , Delhi , Poona and Hyderabad are particularly noteworthy, housing a number of established and emerging firms specializing in the formulation of this crucial